ConvaTec consensus in focus, analysts see upside for the shares

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 21:52.

ConvaTec (GB00BD3VFW73) shows a marked gap between the London share price and prevailing analyst targets. Consensus data from London puts the average target around 306 pence, compared with a recent close near 205 pence on the LSE.MarketBeat consensus overview

What the analysts project

On the London Stock Exchange, ConvaTec trades under the ticker CTEC, with recent quotes around 206.8 pence and a market capitalization near £4.0 billion.Investing.com price and consensus page MarketBeat reports a consensus rating of "Moderate Buy" and an average price target of 306 pence per share, implying double-digit percentage upside from current levels.MarketBeat consensus overview

According to a recent fair value analysis that references targets from JPMorgan, Citi and Morgan Stanley, updated price objectives in the sector range roughly between 230 pence and just over 300 pence, illustrating a spread in views but a generally constructive stance on the stock.Analyst fair value discussion

Valuation, dividend and peer context

ConvaTec shares recently changed hands at around 206.8 pence in London, with a trailing price-earnings ratio reported in the mid-teens and a dividend yield close to 2.6 percent.Hargreaves Lansdown share data The company paid a dividend of approximately 4 pence per share, with the last ex-dividend date on 16 April 2026 and payment on 28 May 2026.Hargreaves Lansdown share data

Within the broader medical technology and wound-care segment, ConvaTec competes with international names such as Smith & Nephew and Coloplast, where valuation multiples and dividend yields serve as important reference points for institutional investors tracking the sector.

How ConvaTec earns its money

ConvaTec generates revenue from medical products and technologies in advanced wound care, ostomy care, continence and critical care, as well as infusion-care solutions for chronic conditions. The portfolio includes branded wound dressings such as Aquacel, which use Hydrofiber technology for moisture management.

Where the shares trade today

The ConvaTec shares (GB00BD3VFW73) trade on the London Stock Exchange under the ticker CTEC and recently quoted around 206.8 pence, based on late-June 2026 pricing in British pounds.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.